Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32201449.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Indian+J+Pharmacol 2020 ; 52 (1): 56-65 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Drug targets for corona virus: A systematic review #MMPMID32201449
Indian J Pharmacol 2020[Jan]; 52 (1): 56-65 PMID32201449show ga
The 2019-novel coronavirus (nCoV) is a major source of disaster in the 21(th) century. However, the lack of specific drugs to prevent/treat an attack is a major need at this current point of time. In this regard, we conducted a systematic review to identify major druggable targets in coronavirus (CoV). We searched PubMed and RCSB database with keywords HCoV, NCoV, corona virus, SERS-CoV, MERS-CoV, 2019-nCoV, crystal structure, X-ray crystallography structure, NMR structure, target, and drug target till Feb 3, 2020. The search identified seven major targets (spike protein, envelop protein, membrane protein, protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs.
|*Drug Design[MESH]
|Betacoronavirus/chemistry/*drug effects[MESH]
|COVID-19[MESH]
|COVID-19 Drug Treatment[MESH]
|Coronavirus Infections/*drug therapy[MESH]
|Humans[MESH]
|Middle East Respiratory Syndrome Coronavirus[MESH]
free
free
free
Indian+J+Pharmacol 2020 ; 52 (1): 56-65
